Can AI Predict Heart Attacks Early? Why Doctors Are Using New Data to Spot Risk Years Ahead

Cardiovascular diseases (CVDs) remain the world's leading cause of death, accounting for approximately 19.8 million fatalities in 2022 alone. For decades, our approach to heart health has largely been reactive, responding to symptoms or established risk factors. But what if we could see the danger coming years, even a decade or more, before a crisis? My research reveals that artificial intelligence is making this a reality, fundamentally shifting the paradigm from reaction to proactive prediction by uncovering hidden signals in data we already collect.

I’ve found that doctors are now leveraging AI to analyze an astonishing array of patient data – from routine blood tests and ECGs to eye scans and even bone density images – to identify cardiovascular risk with unprecedented accuracy and lead times. This isn't just about faster diagnoses; it's about providing a profound window into future health, enabling interventions long before symptoms even begin.

The Invisible Clues: AI's New Diagnostic Toolkit

The most striking advancements I've observed are in how AI is transforming routine medical tests into powerful predictive tools. Consider the new AI-powered tool, CardiOmicScore, developed by a research team at the University of Hong Kong (HKUMed). Announced in May 2026, this system uses a single blood test to estimate a person's future risk of six major cardiovascular diseases, including coronary artery disease, stroke, and heart failure, up to 15 years in advance. It does this by converting complex multiomics measurements into personalized risk scores, performing substantially better than conventional methods. This capability moves precision medicine towards a more dynamic approach, reflecting the body's real-time health status through molecular signals.

Another significant breakthrough comes from Mass General Brigham and the Broad Institute. Their ECG2Stroke model, published in May 2026, can predict stroke risk up to 10 years into the future using only a single, inexpensive, 10-second electrocardiogram (ECG) combined with a patient's age and sex. This is remarkable because ECGs are a standard, non-invasive test. The AI captures subtle waveform patterns that human eyes might miss, offering a scalable solution to identify high-risk individuals for early intervention, especially for strokes caused by blood clots.

Beyond the Obvious: Unpacking Hidden Risk Factors

AI's ability to extract information from existing imaging data is equally revolutionary. I found that traditionally, calcium scores from CT scans have been a key indicator for heart disease. However, new AI-powered analysis of coronary CT angiography (CCTA) goes far beyond this, revealing the total plaque burden, including non-calcified plaques that are invisible to calcium scoring alone but are critical determinants of risk. In fact, patients undergoing CCTA with detailed AI-powered plaque assessment have experienced up to a 41% lower risk of heart attack or cardiac death compared to standard evaluation. This personalized approach has improved prediction of major cardiovascular events from 62% to 75% when plaque quantification was added to risk models.

Mayo Clinic researchers, in March and May 2026, further demonstrated how AI can uncover hidden risks by measuring pericardial adipose tissue (PAT) volume – the fat surrounding the heart – from standard coronary artery calcium (CAC) CT scans. This AI-derived measurement is an independent predictor of CVD risk, significantly improving long-term risk prediction, even in individuals with a zero CAC score who might traditionally be considered low risk. Patients with PAT volume in the highest tertile showed a 30% higher CVD risk, even after accounting for other risk factors.

Even your eye doctor could soon be a frontline defense against heart disease. The CLAiR system, developed by Toku and presented at the American College of Cardiology's Annual Scientific Session (ACC.26) in March 2026, uses AI to assess cardiovascular risk from retinal images captured during routine eye exams. This system showed a strong correlation with standard cardiovascular risk assessments, identifying at-risk individuals with 91.1% sensitivity and 86.2% specificity. This integration means that a routine eye check-up could become an opportunistic screening point, alerting individuals to potential heart issues they weren't aware of.

My research also highlighted an Australian breakthrough from Edith Cowan University in May 2026, where AI technology can detect abdominal aortic calcification – an early warning sign of CVD – using existing DEXA bone density machines. What's truly impressive is that this AI processes scans in just an hour, a task that would take imaging experts two years for manual analysis. This dramatically speeds up the identification of risk in a population where studies show one in five middle-aged and older people have moderate to high disease levels, making them two to three times more likely to suffer a heart attack or stroke.

The Power of Precision: Years, Not Months, of Warning

The ability to predict risk years in advance is the game-changer. It shifts the focus from managing a disease once it manifests to preventing it from ever taking hold. The AI tool for heart failure prediction, detailed in April 2026, can detect the risk of heart failure up to five years before symptoms appear by analyzing subtle changes in the fat surrounding the heart from routine cardiac CT scans. This AI achieved approximately 86% accuracy, identifying high-risk patients who were 20 times more likely to develop heart failure within five years. This profound foresight allows doctors and patients to implement lifestyle changes, medication, and closer monitoring, potentially averting serious health crises. At THT 2026, the EchoNext model was highlighted, demonstrating how AI-ECG can serve as a “safety net for patients with undiagnosed heart failure,” often ordering more necessary echocardiograms than physicians might in routine care.

Democratizing Prevention: Accessible Screening for Millions

I believe the most valuable insight here is how AI is democratizing early detection. Many of these technologies leverage existing, widely available tests, integrating advanced analytics into routine care pathways. This means that personalized, highly accurate cardiovascular risk assessment is becoming accessible to millions, not just those with specific symptoms or access to highly specialized clinics. It creates opportunities for proactive health management on an unprecedented scale, allowing individuals to make informed decisions about their health trajectory with years of warning.

Bottom line: AI is revolutionizing heart health by transforming routine data into powerful predictive insights, offering years of advance warning for cardiovascular diseases. This shift from reactive treatment to proactive prevention means more lives can be saved and quality of life improved through timely interventions based on previously undetectable risks. I urge everyone to discuss these new AI-powered screening possibilities with their healthcare providers to leverage this incredible foresight.